Revance Therapeutics Inc (RVNC)

4.13 +0.68 (+19.71%) USD  |  NASDAQ  |  Nov 12, 16:00
4.13 0.00 (0.00%) After-Hours: 20:00
More

Revance Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for RVNC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual Revenue Estimates Data

View and export this data back to 2022. Upgrade now.
Date Value
December 31, 2026 --
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2023 --
December 31, 2022 --

Annual Revenue Estimates Range, Past 5 Years

Upgrade
Minimum
2022
Upgrade
Maximum
2026
Upgrade
Average
Upgrade
Median
2024

Annual Revenue Estimates Benchmarks

Recursion Pharmaceuticals Inc Upgrade
Moderna Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
MEI Pharma Inc Upgrade
GlycoMimetics Inc Upgrade